Where does Acucela Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Acucela Inc. ranks #4,315 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Acucela Inc. hold?

Acucela Inc. holds 82 US utility patents granted between 2015 and 2025, spanning 22 technology areas.

What is Acucela Inc.'s Innovation Score?

Acucela Inc. has an Innovation Score of 61.4 out of 100 (top 3% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Acucela Inc.'s patent grant rate increasing or decreasing?

Acucela Inc.'s recent grant velocity is +217% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Acucela Inc.'s patents?

Acucela Inc.'s patents average 15.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Acucela Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Acucela Inc.

Q: What technology areas does Acucela Inc. focus on?

Acucela Inc.'s top technology area is G02C (SPECTACLES; Sunglasses OR Goggles Insofar AS They Have THE Same Features AS SPECTACLES; Contact Lenses) with 34 patents. Grants appear in 22 CPC subclasses total.

USPTO PatentsView assignee record - 82 granted patents across 22 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G02C (SPECTACLES; Sunglasses OR Goggles Insofar AS They Have THE Same Features AS SPECTACLES; Contact Lenses).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Acucela ranks #4,315 of 49,997 tracked US assignees by granted-patent volume, with 82 patents across 22 technology areas.

#4,315
of 49,997 US assignees by volume: Top 3%
by Innovation Score (61.4/100): 15.9
avg claims per patent: +217%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4315 · US Corporation #4,315 · 82 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 82 grants
TOP-DECILE #4,315/49,997
PHOTO-FINISH Airoha Technology
CPC-FOCUS G02C · 22 areas
INNOV-STRONG 61.4/100
CLAIMS-RICH 15.9 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +217% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Airoha Technology Corp. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Leonardo S P A · near

61
Sleep Number · near

61
Acucela · this assignee

61
Ethicon · near

61
Novo Nordisk A/S · near

61
3D Lighting… · lowest

7

What this shows Acucela's Innovation Score is 61.4/100 (top 3% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Acucela's grants concentrate

Acucela Inc. is a focused PatentsView assignee: 22 CPC subclasses with 41.5% of grants classified under G02C (SPECTACLES; Sunglasses OR Goggles Insofar AS They Have THE Same Features AS SPECTACLES; Contact Lenses). Peak complete grant year is 2022 (21 grants) versus a trough of 1 in 2017. By volume, Acucela sits between University OF North Texas and Antares Pharma, Inc..

Acucela's three-year grant acceleration

Acucela Inc. shows 51 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

University OF Nor…

83
Vonage Business

83
Winston Products

83
Yellowpages COM

83
Appleton GRP

82
Airoha Technology

82
Andersen

82
Antares Pharma

82
Acucela ◀

82

What this shows Acucela holds 82 patents at rank #4,315, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Acucela

By rank, the assignees closest to #4,315 in granted patent volume.

Leaders in G02C (Spectacles)

Other assignees with the most granted patents in Acucela's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Acucela, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (61 here).

Novo Nordisk A/S 61 Ethicon, Inc. 61 Leonardo S.P.A. 61 Sleep Number Corporation 61

Similar claim depth

Nearest assignees by average claims per patent (15.9 here).

F-Secure Corporation 15.9 avg Modine Manufacturing Company 15.9 avg Recaro Aircraft Seating GmbH & Co. KG 15.9 avg Dresser-rand Company 15.9 avg

Acucela's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

61 Top 3% higher than 97% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Acucela Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	7	8.5%
2016	6	7.3%
2017	1	1.2%
2018	1	1.2%
2019	3	3.7%
2020	3	3.7%
2021	3	3.7%
2022	21	25.6%
2023	17	20.7%
2024	13	15.9%
2025partial year	7	8.5%

Which technologies does Acucela Inc. patent most?

G02C - SPECTACLES; Sunglasses OR Goggles Insofar AS They Have THE Same Features AS SPECTACLES; Contact Lenses 34

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 25

C07D - Heterocyclic Compounds 25

C07C - Acyclic OR Carbocyclic Compounds 20

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 20

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 20

A61B - DIAGNOSIS; SURGERY; Identification 20

G02B - Optical Elements, Systems OR Apparatus 17

G01B - Measuring Length, Thickness OR Similar Linear DIMENSIONS; Measuring ANGLES; Measuring AREAS; Measuring Irregularities OF Surfaces OR Contours 17

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 8

A45C - PURSES; LUGGAGE; Hand Carried Bags 6

H01S - Devices Using THE Process OF Light Amplification BY Stimulated Emission OF Radiation [LASER] TO Amplify OR Generate LIGHT; Devices Using Stimulated Emission OF Electromagnetic Radiation IN Wave Ranges Other Than Optical 5

G06V - Image OR Video Recognition OR Understanding 3

G06N - Computing Arrangements Based ON Specific Computational Models 3

G06T - Image Data Processing OR Generation, IN General 3

Top 15 of 22 technology areas

Where it ranks

Overall rank by patents

#4,315

of 49,997 tracked assignees

Innovation Score

61.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Acucela Inc.'s patent record in context - here's where to go next.

Acucela Inc.'s lead technology class is G02C (SPECTACLES; Sunglasses OR Goggles Insofar AS They Have THE Same Features AS SPECTACLES; Contact Lenses), 41.5% of its portfolio - see every assignee active in that class. Explore G02C
Ranked #4,315 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Acucela Inc. against University OF North Texas, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 61.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.